406 related articles for article (PubMed ID: 27196480)
1. Bacteremic Urinary Tract Infection Caused by Multidrug-Resistant Enterobacteriaceae Are Associated With Severe Sepsis at Admission: Implication for Empirical Therapy.
Lee YC; Hsiao CY; Hung MC; Hung SC; Wang HP; Huang YJ; Wang JT
Medicine (Baltimore); 2016 May; 95(20):e3694. PubMed ID: 27196480
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for severe sepsis in community-onset bacteraemic urinary tract infection: impact of antimicrobial resistance in a large hospitalised cohort.
Shaw E; Benito N; Rodríguez-Baño J; Padilla B; Pintado V; Calbo E; Pallarés MA; Gozalo M; Ruiz-Garbajosa P; Horcajada JP;
J Infect; 2015 Mar; 70(3):247-54. PubMed ID: 25305497
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for Enterococcus faecalis in complicated community-acquired urinary tract infections in older patients.
Madrazo M; Esparcia A; Alberola J; Ferrer A; Eiros JM; Nogueira JM; Artero A
Geriatr Gerontol Int; 2020 Mar; 20(3):183-186. PubMed ID: 31876112
[TBL] [Abstract][Full Text] [Related]
4. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.
Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
BMC Infect Dis; 2017 Apr; 17(1):279. PubMed ID: 28415969
[TBL] [Abstract][Full Text] [Related]
5. Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China.
Jiang AM; Shi X; Liu N; Gao H; Ren MD; Zheng XQ; Fu X; Liang X; Ruan ZP; Yao Y; Tian T
BMC Infect Dis; 2020 Jun; 20(1):452. PubMed ID: 32600270
[TBL] [Abstract][Full Text] [Related]
6. Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy.
Burnham JP; Lane MA; Kollef MH
Crit Care Med; 2015 Aug; 43(8):1580-6. PubMed ID: 25855900
[TBL] [Abstract][Full Text] [Related]
7. Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis?
Stupica D; Lusa L; Klevišar MN; Terzić S; Pirš M; Premru MM; Strle F
Int J Antimicrob Agents; 2017 Oct; 50(4):564-571. PubMed ID: 28711676
[TBL] [Abstract][Full Text] [Related]
8. Intravenous-only or Intravenous Transitioned to Oral Antimicrobials for Enterobacteriaceae-Associated Bacteremic Urinary Tract Infection.
Rieger KL; Bosso JA; MacVane SH; Temple Z; Wahlquist A; Bohm N
Pharmacotherapy; 2017 Nov; 37(11):1479-1483. PubMed ID: 28869655
[TBL] [Abstract][Full Text] [Related]
9. Mortality impact of empirical antimicrobial therapy in ESBL- and AmpC-producing Enterobacteriaceae bacteremia in an Australian tertiary hospital.
Lim CL; Spelman D
Infect Dis Health; 2019 Aug; 24(3):124-133. PubMed ID: 30928569
[TBL] [Abstract][Full Text] [Related]
10. Infection in cirrhosis: A prospective study.
Bhattacharya C; Das-Mondal M; Gupta D; Sarkar AK; Kar-Purkayastha S; Konar A
Ann Hepatol; 2019; 18(6):862-868. PubMed ID: 31635968
[TBL] [Abstract][Full Text] [Related]
11. A Cohort Study of the Impact of Carbapenem-Resistant
Sabino S; Soares S; Ramos F; Moretti M; Zavascki AP; Rigatto MH
mSphere; 2019 Apr; 4(2):. PubMed ID: 30971443
[TBL] [Abstract][Full Text] [Related]
12. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study.
Zilberberg MD; Shorr AF; Micek ST; Vazquez-Guillamet C; Kollef MH
Crit Care; 2014 Nov; 18(6):596. PubMed ID: 25412897
[TBL] [Abstract][Full Text] [Related]
13. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
14. The clinical impact of bacteremia in complicated acute pyelonephritis.
Hsu CY; Fang HC; Chou KJ; Chen CL; Lee PT; Chung HM
Am J Med Sci; 2006 Oct; 332(4):175-80. PubMed ID: 17031242
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing antimicrobial resistance and outcome of Gram-negative bloodstream infections in children.
Ivády B; Kenesei É; Tóth-Heyn P; Kertész G; Tárkányi K; Kassa C; Ujhelyi E; Mikos B; Sápi E; Varga-Heier K; Guóth G; Szabó D
Infection; 2016 Jun; 44(3):309-21. PubMed ID: 26546372
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.
Russo A; Giuliano S; Ceccarelli G; Alessandri F; Giordano A; Brunetti G; Venditti M
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555630
[TBL] [Abstract][Full Text] [Related]
17. Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
Russo A; Falcone M; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Cisneros JM; Hernández-Torres A; Farcomeni A; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Mora-Rillo M; Rodriguez-Gomez J; Souli M; Bonomo RA; Paterson DL; Carmeli Y; Pascual A; Rodríguez-Baño J; Venditti M;
Int J Antimicrob Agents; 2018 Nov; 52(5):577-585. PubMed ID: 29969692
[TBL] [Abstract][Full Text] [Related]
18. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
[TBL] [Abstract][Full Text] [Related]
19. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes.
Chen CY; Chen YH; Lu PL; Lin WR; Chen TC; Lin CY
J Microbiol Immunol Infect; 2012 Jun; 45(3):228-36. PubMed ID: 22572004
[TBL] [Abstract][Full Text] [Related]
20. Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials.
Burnham JP; Micek ST; Kollef MH
PLoS One; 2017; 12(7):e0180247. PubMed ID: 28678812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
